United Therapeutics enters $2.5B revolving credit facility, repays $200M of existing debt

UNITED THERAPEUTICS Corp

New $2.5B unsecured revolving credit facility, with option to increase by up to $750M.
Borrowed $200M at closing to repay outstanding indebtedness under 2022 credit agreement.
Five-year maturity, with two potential one-year extensions at lenders' option.
Financial covenants: consolidated total leverage ≤3.50x and interest coverage ≥3.00x.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.